Deep sedation may be safer than general anesthesia for elderly ERCP patients

NCT ID NCT07017283

First seen Jan 11, 2026 · Last updated Jun 22, 2026 · Updated 24 times

Summary

This study compares deep sedation with a nasal airway to general anesthesia with a breathing tube in 170 elderly patients (60+) undergoing ERCP for bile or pancreas issues. The goal is to see which method causes fewer breathing problems during and after the procedure. Researchers will also track recovery time and other side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BILIARY AND PANCREATIC DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sir Run Run Shaw Hospital, Zhejiang University School of Medicine

    RECRUITING

    Hangzhou, Zhijiang, 310016, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Procedure: deep analgosedation with nasopharyngeal airway vs. endotracheal intubation general anesthesia

What this could lead to

If successful, this could show that deep sedation with a nasal airway is safer and equally effective as general anesthesia for elderly ERCP patients, potentially reducing recovery time and complications.

What could go wrong

This is a small, early-stage trial (170 participants) comparing two anesthesia methods, so results may not apply to all patients. The open-label design could introduce bias, and the primary focus is on breathing events, not long-term outcomes.

Conditions

The condition(s) this trial relates to.

pancreas disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.